Value of ultrafast and standard dynamic contrast-enhanced magnetic resonance imaging in the evaluation of the presence and extension of residual disease after neoadjuvant chemotherapy in breast cancer-Reference-Cited by-同舟云学术

Value of ultrafast and standard dynamic contrast-enhanced magnetic resonance imaging in the evaluation of the presence and extension of residual disease after neoadjuvant chemotherapy in breast cancer

Published:2021-03-20 Issue:8 Volume:39 Page:791-801
ISSN:1867-1071
Container-title:Japanese Journal of Radiology
language:en
Short-container-title:Jpn J Radiol

Author:

Kato Erina,Mori Naoko^ORCID,Mugikura Shunji,Sato Satoko,Ishida Takanori,Takase Kei

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s11604-021-01110-y.pdf

Reference36 articles.

1. King TA, Morrow M. Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy. Nat Rev Clin Oncol. 2015;12:335–43.

2. Kobayashi K, Horii R, Ito Y, Miyagi Y, Ohno S, Iwase T, et al. Prognostic significance of histological therapeutic effect in preoperative chemotherapy for breast cancer: prognostic analysis in breast cancer. Pathol Int. 2016;66:8–14.

3. Chaturvedi S, McLaren C, Schofield AC, Ogston KN, Sarkar TK, Hutcheon AW, et al. Patterns of local and distant disease relapse in patients with breast cancer treated with primary chemotherapy: do patients with a complete pathological response differ from those with residual tumour in the breast? Breast Cancer Res Treat. 2005;93:151–8.

4. Mukai H, Arihiro K, Shimizu C, Masuda N, Miyagi Y, Yamaguchi T, et al. Stratifying the outcome after neoadjuvant treatment using pathological response classification by the Japanese Breast Cancer Society. Breast Cancer. 2016;23:73–7.

5. von Minckwitz G, Huang C-S, Mano MS, Loibl S, Mamounas EP, Untch M, et al. Trastuzumab emtansine for residual invasive HER2-Positive Breast Cancer. N Engl J Med. 2019;380(7):617–28.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Performance of Radiomic Features Extracted from Breast MR Imaging in Postoperative Upgrading of Ductal Carcinoma <i>in Situ</i> to Invasive Carcinoma;Magnetic Resonance in Medical Sciences;2024

2. Ultrafast Dynamic Contrast‐Enhanced MRI of the Breast: From Theory to Practice;Journal of Magnetic Resonance Imaging;2023-12-12

3. Role of conventional dynamic contrast-enhanced MRI and ultrafast MRI in breast cancer patients receiving neoadjuvant chemotherapy: prediction of pathologic complete response and radiopathologic correlation using microvessel density;2023-11-21

4. Value of dynamic contrast-enhanced magnetic resonance imaging in combination with mammography for screening early-stage breast cancer;African Health Sciences;2023-07-13

5. Application of triple evaluation method in predicting the efficacy of neoadjuvant therapy for breast cancer;World Journal of Surgical Oncology;2023-03-29